CO6180426A2 - Compuesto para el tratamiento de la hepatitis b - Google Patents
Compuesto para el tratamiento de la hepatitis bInfo
- Publication number
- CO6180426A2 CO6180426A2 CO09097263A CO09097263A CO6180426A2 CO 6180426 A2 CO6180426 A2 CO 6180426A2 CO 09097263 A CO09097263 A CO 09097263A CO 09097263 A CO09097263 A CO 09097263A CO 6180426 A2 CO6180426 A2 CO 6180426A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- hydrogen
- cycloalkyl
- alkylso2
- tetrahydrofuranyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
1.- Un compuesto de la fórmula Icaracterizado porque:R1 es CO2R5 o CONR6R7; R2 esR3 es hidrógeno, halo, alquilo, alquenilo, hidroxi, benciloxi, o alcoxi; R4 es cicloalquilo; R5 es hidrógeno o alquilo; R6 es hidrógeno, alquilo, alquiloSO2, alqueniloSO2, cicloalquiloSO2, (cicloalquilo) alquiloSO2, haloalquiloSO2, (R9) (R10)NSO2, o (R11)SO2;R7 es hidrógeno o alquilo; R8 es hidrógeno, alquilo, cicloalquilo, (cicloalquilo)alquilo, hidroxialquilo, alcoxialquilo, alquilcarbonilo, cicloalquilcarbonilo, haloalquilcarbonilo, alcoxicarbonilo, alquiloSO2, cicloalquiloSO2, haloalquiloSO2, aminocarbonilo, (alquilamino) carbonilo, (dialquilamino) carbonilo, bencilo, benciloxicarbonilo, o piridinilo; R9 es hidrógeno o alquilo; R10 es hidrógeno o alquilo; R11 es azetidinilo, pirrolidinilo, piperidinilo, N-(R12)piperazinilo, morfolinilo, tiomorfolinilo, homopiperidinilo, homomorfolinilo, tetrahidrofuranilo, tetrahidropiranilo, (tetrahidrofuranil)alquilo, o (tetrahidropiranil) alquilo; y R12 es hidrógeno o alquilo; o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89488707P | 2007-03-14 | 2007-03-14 | |
US98947407P | 2007-11-21 | 2007-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6180426A2 true CO6180426A2 (es) | 2010-07-19 |
Family
ID=39477552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09097263A CO6180426A2 (es) | 2007-03-14 | 2009-09-10 | Compuesto para el tratamiento de la hepatitis b |
Country Status (19)
Country | Link |
---|---|
US (1) | US7547690B2 (es) |
EP (1) | EP2118109B1 (es) |
JP (1) | JP5232178B2 (es) |
KR (1) | KR20100015304A (es) |
CN (1) | CN101657455B (es) |
AR (1) | AR065772A1 (es) |
AU (1) | AU2008226639B2 (es) |
BR (1) | BRPI0808763A2 (es) |
CA (1) | CA2681093A1 (es) |
CL (1) | CL2008000751A1 (es) |
CO (1) | CO6180426A2 (es) |
EA (1) | EA016614B1 (es) |
IL (1) | IL200905A0 (es) |
MX (1) | MX2009009473A (es) |
NZ (1) | NZ579342A (es) |
PE (1) | PE20090648A1 (es) |
TW (1) | TW200848058A (es) |
WO (1) | WO2008112473A1 (es) |
ZA (1) | ZA200906129B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1688420A4 (en) * | 2003-11-19 | 2008-10-22 | Japan Tobacco Inc | 5-5 LOW-CONDENSED HETEROCYCLIC COMPOUND AND THEIR USE AS HCV POLYMERASE INHIBITOR |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
US7521443B2 (en) * | 2006-05-17 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7642251B2 (en) * | 2007-08-09 | 2010-01-05 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8143243B2 (en) * | 2007-08-09 | 2012-03-27 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7652004B2 (en) * | 2007-08-09 | 2010-01-26 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
PL2209789T3 (pl) * | 2007-11-20 | 2012-04-30 | Bristol Myers Squibb Co | Skondensowane z cyklopropylem indolobenzoazepinowe inhibitory NS5B HCV |
US8129367B2 (en) * | 2007-11-21 | 2012-03-06 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US8124601B2 (en) | 2007-11-21 | 2012-02-28 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
CA2710644C (en) | 2007-12-24 | 2016-03-29 | Tibotec Pharmaceuticals | Macrocyclic indoles as hepatitis c virus inhibitors |
MX2010010061A (es) * | 2008-03-27 | 2010-09-30 | Bristol Myers Squibb Co | Compuestos para el tratamiento de hepatitis c. |
EP2280978B1 (en) * | 2008-03-27 | 2013-04-24 | Bristol-Myers Squibb Company | Pyrrolidine fused indolobenzadiazepine hcv ns5b inhibitors |
EP2268643B1 (en) * | 2008-03-27 | 2014-08-06 | Bristol-Myers Squibb Company | Dioxolane and dioxolanone fused indolobenzadiazepine hcv ns5b inhibitors |
US8133884B2 (en) * | 2008-05-06 | 2012-03-13 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8143244B2 (en) * | 2009-02-26 | 2012-03-27 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
EP2509982A1 (en) * | 2009-12-07 | 2012-10-17 | Targacept, Inc. | 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands |
US8716275B2 (en) * | 2011-10-20 | 2014-05-06 | Bristol-Myers Squibb Company | Compound for the treatment of hepatitis C |
WO2014011863A1 (en) * | 2012-07-12 | 2014-01-16 | Targacept, Inc. | Method of treatment with 3-cyclopropylcarbonyl-3,6-diazabicyclo[3.1.1]heptane |
AU2013290402A1 (en) * | 2012-07-18 | 2015-03-05 | Bristol-Myers Squibb Holdings Ireland | Novel methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1 r,5s) -3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide |
MX2018011214A (es) | 2016-03-15 | 2019-03-28 | Bayer Cropscience Ag | Sulfonamidas sustituidas para controlar plagas animales. |
TW201822637A (zh) | 2016-11-07 | 2018-07-01 | 德商拜耳廠股份有限公司 | 用於控制動物害蟲的經取代磺醯胺類 |
CN110028510A (zh) * | 2019-05-22 | 2019-07-19 | 南京合巨药业有限公司 | 一种3-甲基-3,6-二氮杂-双环[3,1,1]庚烷二盐酸盐的制备方法 |
JP2023501978A (ja) | 2019-11-07 | 2023-01-20 | バイエル・アクチエンゲゼルシヤフト | 動物害虫駆除用の置換スルホニルアミド |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1719773E (pt) | 2004-02-24 | 2009-06-03 | Japan Tobacco Inc | Compostos heterotetracíclicos fundidos e a sua utilização como inibidores da polimerase do hcv |
US7348425B2 (en) | 2004-08-09 | 2008-03-25 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
US7153848B2 (en) | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
CA2585113A1 (en) | 2004-10-26 | 2006-05-04 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Tetracyclic indole derivatives as antiviral agents |
GB0518390D0 (en) | 2005-09-09 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
US7399758B2 (en) | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7473688B2 (en) | 2005-09-13 | 2009-01-06 | Bristol-Myers Squibb Company | Indolobenzazepine HCV NS5B inhibitors |
US7456165B2 (en) | 2006-02-08 | 2008-11-25 | Bristol-Myers Squibb Company | HCV NS5B inhibitors |
GB0608928D0 (en) | 2006-05-08 | 2006-06-14 | Angeletti P Ist Richerche Bio | Therapeutic agents |
US7456166B2 (en) | 2006-05-17 | 2008-11-25 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7521441B2 (en) | 2006-05-22 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
WO2007140200A2 (en) | 2006-05-25 | 2007-12-06 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
ES2343914T3 (es) | 2006-05-25 | 2010-08-12 | Bristol-Myers Squibb Company | Inhibidores de ns5b de hcv de indolobenzazepina condensada con ciclopropilo. |
US7452876B2 (en) | 2006-06-08 | 2008-11-18 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
-
2008
- 2008-02-28 US US12/039,239 patent/US7547690B2/en active Active
- 2008-03-05 JP JP2009553689A patent/JP5232178B2/ja not_active Expired - Fee Related
- 2008-03-05 CN CN200880008369XA patent/CN101657455B/zh not_active Expired - Fee Related
- 2008-03-05 WO PCT/US2008/055893 patent/WO2008112473A1/en active Application Filing
- 2008-03-05 EP EP08743684.6A patent/EP2118109B1/en not_active Not-in-force
- 2008-03-05 MX MX2009009473A patent/MX2009009473A/es not_active Application Discontinuation
- 2008-03-05 NZ NZ579342A patent/NZ579342A/en not_active IP Right Cessation
- 2008-03-05 AU AU2008226639A patent/AU2008226639B2/en not_active Ceased
- 2008-03-05 BR BRPI0808763-6A patent/BRPI0808763A2/pt not_active IP Right Cessation
- 2008-03-05 EA EA200901241A patent/EA016614B1/ru not_active IP Right Cessation
- 2008-03-05 KR KR1020097019018A patent/KR20100015304A/ko not_active Application Discontinuation
- 2008-03-05 CA CA002681093A patent/CA2681093A1/en not_active Abandoned
- 2008-03-13 CL CL200800751A patent/CL2008000751A1/es unknown
- 2008-03-13 PE PE2008000473A patent/PE20090648A1/es not_active Application Discontinuation
- 2008-03-13 TW TW097108906A patent/TW200848058A/zh unknown
- 2008-03-14 AR ARP080101085A patent/AR065772A1/es not_active Application Discontinuation
-
2009
- 2009-09-03 ZA ZA2009/06129A patent/ZA200906129B/en unknown
- 2009-09-10 CO CO09097263A patent/CO6180426A2/es active IP Right Grant
- 2009-09-13 IL IL200905A patent/IL200905A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0808763A2 (pt) | 2014-09-16 |
EP2118109B1 (en) | 2014-11-26 |
US20080227769A1 (en) | 2008-09-18 |
KR20100015304A (ko) | 2010-02-12 |
CN101657455A (zh) | 2010-02-24 |
IL200905A0 (en) | 2010-05-17 |
AU2008226639A1 (en) | 2008-09-18 |
US7547690B2 (en) | 2009-06-16 |
PE20090648A1 (es) | 2009-05-29 |
EA200901241A1 (ru) | 2010-02-26 |
MX2009009473A (es) | 2009-09-15 |
EA016614B1 (ru) | 2012-06-29 |
JP2010521476A (ja) | 2010-06-24 |
JP5232178B2 (ja) | 2013-07-10 |
NZ579342A (en) | 2011-07-29 |
EP2118109A1 (en) | 2009-11-18 |
AU2008226639B2 (en) | 2012-07-19 |
TW200848058A (en) | 2008-12-16 |
AR065772A1 (es) | 2009-07-01 |
CA2681093A1 (en) | 2008-09-18 |
ZA200906129B (en) | 2010-11-24 |
WO2008112473A1 (en) | 2008-09-18 |
CN101657455B (zh) | 2013-02-06 |
CL2008000751A1 (es) | 2008-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6180426A2 (es) | Compuesto para el tratamiento de la hepatitis b | |
AR061008A1 (es) | Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo | |
GEP20125456B (en) | Azetidines as mek inhibitors for the treatment of proliferative diseases | |
CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
IN2012DN00999A (es) | ||
AR061053A1 (es) | Inhibidores ns5b del virus de hepatitis c de indolobenzazepina fusionados a ciclopropilo | |
AR057810A1 (es) | Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo y composicion farmaceutica | |
GEP20084421B (en) | Proline derivatives and their use as dipeptidyl peptidase iv inhibitors | |
GEP20105053B (en) | Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors | |
TW200740815A (en) | P38 MAP kinase inhibitors and methods for using the same | |
AR067528A1 (es) | Eteres heterociclicos sustituidos y su uso en trastornos del snc | |
MX2009003157A (es) | Pirazoliltienopiridinas terapeuticas. | |
RS20090249A (en) | Spiroketone acetyl-coa carboxylase inhibotors | |
TW200738242A (en) | Dihydropteridinones in the treatment of respiratory diseases | |
TW200718689A (en) | 2-Amino-quinazolin-5-ones | |
IL177962A0 (en) | Compounds and methods for treating dyslipidemia | |
JP2010521483A5 (es) | ||
AR055165A1 (es) | Inhibidores ns5b de vhc de indolobenzacepina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la hepatitis c. | |
AR035991A1 (es) | Derivados de benzimidazoles e imidazopiridinas, un procedimiento para su preparacion, composiciones farmaceuticas, un procedimiento para su preparacion, y un medicamento utiles como inhibidores de la replicacion del virus sincitial respiratorio | |
MX2012007420A (es) | Analogos para el tratamiento o prevencion de infecciones de flavivirus. | |
GB0413087D0 (en) | Therapeutic compounds | |
MXPA06000716A (es) | Derivados de quinolina y quinazolina que tienen afinidad hacia receptores del tipo 5ht1. | |
MX2007004183A (es) | Derivados de benzoimidazol utiles como agentes antiproliferacion. | |
IL205697A0 (en) | 4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazole-2-yl)benzenesulfon-amide derivatives, compositions comprising the same and uses thereof | |
MX2012006962A (es) | Inhibidores de la esfingosina quinasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |